Plasmodium falciparum malaria challenge by the bite of aseptic Anopheles stephensi mosquitoes: results of a randomized infectivity trial - Test2 - elhamkhani - TriplyDB

Plasmodium falciparum malaria challenge by the bite of aseptic Anopheles stephensi mosquitoes: results of a randomized infectivity trial

Plasmodium falciparum malaria challenge by the bite of aseptic Anopheles stephensi mosquitoes: results of a randomized infectivity trial

http://www.wikidata.org/entity/Q28748765

about

sameAs

Vaccines for malaria: how close are we?Protection against malaria at 1 year and immune correlates following PfSPZ vaccination External quality assurance of malaria nucleic acid testing for clinical trials and eradication surveillance Plasmodium vivax sporozoite challenge in malaria-naïve and semi-immune Colombian volunteers Safety and comparability of controlled human Plasmodium falciparum infection by mosquito bite in malaria-naïve subjects at a new facility for sporozoite challenge Controlled human malaria infection of Tanzanians by intradermal injection of aseptic, purified, cryopreserved Plasmodium falciparum sporozoites.Elimination therapy for the endemic malarias.TB Vaccines: The (Human) Challenge Ahead.Successful human infection with P. falciparum using three aseptic Anopheles stephensi mosquitoes: a new model for controlled human malaria infection.Direct venous inoculation of Plasmodium falciparum sporozoites for controlled human malaria infection: a dose-finding trial in two centres.Impact of malaria preexposure on antiparasite cellular and humoral immune responses after controlled human malaria infection.Robust, reproducible, industrialized, standard membrane feeding assay for assessing the transmission blocking activity of vaccines and drugs against Plasmodium falciparum Controlled human malaria infection by intramuscular and direct venous inoculation of cryopreserved Plasmodium falciparum sporozoites in malaria-naïve volunteers: effect of injection volume and dose on infectivity rates Safety and Reproducibility of a Clinical Trial System Using Induced Blood Stage Plasmodium vivax Infection and Its Potential as a Model to Evaluate Malaria Transmission Optimizing Intradermal Administration of Cryopreserved Plasmodium falciparum Sporozoites in Controlled Human Malaria Infection.Human challenge studies: a review of adequacy of reporting methods and results.Live attenuated pre-erythrocytic malaria vaccines.Attenuated PfSPZ Vaccine induces strain-transcending T cells and durable protection against heterologous controlled human malaria infection Modeling Combinations of Pre-erythrocytic Plasmodium falciparum Malaria Vaccines Mosquito Infectivity and Parasitemia after Controlled Human Malaria Infection

P2860

Q27024344-A8CDF605-3629-48F1-B4B0-20405939D159 Q28049695-314726EA-EDF1-4983-A961-AFF8DF1848BB Q28538917-C0DD904E-9A5F-47C3-AC71-A9F540AAE6B8 Q28539992-55E51974-96BD-4793-9315-3D71262DBC15 Q28545017-9CE31ADB-E78A-45C7-9795-983723850AD9 Q34138437-893C2D85-704F-426B-99AF-D94789F8FA0D Q34194828-5EFEFCC5-0D43-4534-966A-6F37E3F6EA1A Q34676075-BB7442BC-BE4E-44A1-AE26-862F37421D53 Q34852105-450EA968-45B3-4104-B46D-83D0AD3A0AA3 Q35211679-B3F66088-3CA3-40DB-B5B4-3B2495613A10 Q35439859-66FC0EFE-86A2-4241-922C-019C8215B704 Q35817470-DC06A7FB-7F2A-488E-9BA7-19EF2D00BF1D Q35922955-62E70AD9-3C3B-4381-82E4-E0AA9ACD084C Q36215894-A2D0E8D3-0A76-49C4-B886-76CEEAC85007 Q36359296-04EFA908-1061-410D-8AC4-4E9FA8E0B493 Q37996090-6D4C3A2B-F18B-41DD-BD6B-0129806EFA96 Q38284696-80F8D14A-026A-4204-A91D-7340F31C3512 Q38949224-1091F6C7-D8D0-4854-88D7-C8C110EAAB6A Q40390930-9FDA58C3-5825-402F-849D-CAA4BA6160FE Q56379066-3C96D519-E5D0-4C7E-958D-B5603646364B

P2860

Plasmodium falciparum malaria challenge by the bite of aseptic Anopheles stephensi mosquitoes: results of a randomized infectivity trial

http://www.wikidata.org/entity/Q28748765

description

2010 nî lūn-bûn

@nan

2010 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Plasmodium falciparum malaria ...... a randomized infectivity trial

@ast

Plasmodium falciparum malaria ...... a randomized infectivity trial

@en

Plasmodium falciparum malaria ...... a randomized infectivity trial

@nl

type

label

Plasmodium falciparum malaria ...... a randomized infectivity trial

@ast

Plasmodium falciparum malaria ...... a randomized infectivity trial

@en

Plasmodium falciparum malaria ...... a randomized infectivity trial

@nl

prefLabel

Plasmodium falciparum malaria ...... a randomized infectivity trial

@ast

Plasmodium falciparum malaria ...... a randomized infectivity trial

@en

Plasmodium falciparum malaria ...... a randomized infectivity trial

@nl

P1433

Q28748765-C8077687-3833-432A-B56F-87ACA875DB79

P1476

Q28748765-41C7A9D4-7F87-45E1-8822-E8EB8558AF09

P2093

Q28748765-0E9451F4-37ED-41C7-8957-A942B6E485D7

Q28748765-12E77215-67F3-41C4-A24A-1517BE682F5C

Q28748765-42E24FDF-9680-4103-8FF5-C566CE9E9D92

Q28748765-4494B420-92F0-49FB-9352-8AFBEC9EFDCF

Q28748765-6A4D7B6D-CE87-4EA9-83D9-DF65DEEE6162

Q28748765-BC71CC4C-434D-4398-8BDD-361133FD3854

Q28748765-EA6A89FC-1A6E-4323-A292-490EC7B83101

Q28748765-EF7534C2-DE62-4DC1-9DEA-9E6C8CE6A286

P2860

Q28748765-050BA869-8AD4-4504-ABF2-9282D7920DBE

Q28748765-0962DE1D-C7A3-47A5-95B3-86DD8452F122

Q28748765-098A3D4C-CBC7-4F26-ABFA-329E9D431555

Q28748765-0EFC2E80-8C4B-45CD-9A7A-AAE9CF9E2205

Q28748765-1378C155-5A22-47EF-B1D4-9CB7A19C4DE5

Q28748765-1AB158B9-DD60-40FA-9FB2-5FFDDD365F95

Q28748765-21D97CD6-C55A-40B3-A8C2-8E923ACC98DA

Q28748765-43684CCD-1D14-4E81-97AA-ACEE1A93FEBF

Q28748765-48BE9A13-5158-4ADB-990F-71E03D0C01CA

Q28748765-48EBBE72-7863-4CF7-A55A-7456294E1E30

P304

Q28748765-EA0FC3EB-2A21-4899-BF71-555EA2966668

P31

Q28748765-9CE35A16-3102-4F1A-A78C-CC785355AA39

P356

Q28748765-7853641F-2EE4-4E35-B775-6A03E6020E34

P407

Q28748765-46AA4E3E-9CFD-4AE3-B59D-A52BCB05F292

P433

Q28748765-06CDE549-78FE-4577-A51F-88610AAF6030

P478

Q28748765-C980923F-14CC-457E-998A-36048C1F5B03

P50

Q28748765-83F0B9C3-4D0B-4FF7-BF86-0EBD6AB1951F

Q28748765-A2EF3CAF-E351-4001-9E4E-7AD9E6CFE344

Q28748765-EE4D70D5-6B3E-4879-BED5-EBC7CB80E310

P577

Q28748765-299E5861-5851-41E2-A099-2565268FF6AD

P5875

Q28748765-014D2FCF-7DF2-4F1F-80B5-173873557299

P698

Q28748765-93F7DD5D-8FB8-422A-BEBD-7653D7A87DA2

P921

Q28748765-20E69B3B-560A-4B8B-8523-5738E295355D

Q28748765-3EB4D489-B473-4E2E-B939-D8863D048B10

Q28748765-5CB15289-FCE4-4E75-833B-FB28D5F9A3DD

Q28748765-E59A52D0-241F-452A-B59C-578C345DF233

P932

Q28748765-2506F417-C15D-4F2F-8949-410C30C892BE

P356

JOURNAL.PONE.0013490

P1433

P1476

Plasmodium falciparum malaria ...... a randomized infectivity trial

@en

P2093

Adam Richman

http://www.w3.org/2001/XMLSchema#string

B Kim Lee Sim

http://www.w3.org/2001/XMLSchema#string

Kirsten E Lyke

http://www.w3.org/2001/XMLSchema#string

Mark Loyevsky

http://www.w3.org/2001/XMLSchema#string

Matthew Adams

http://www.w3.org/2001/XMLSchema#string

Peter F Billingsley

http://www.w3.org/2001/XMLSchema#string

Robert Edelman

http://www.w3.org/2001/XMLSchema#string

Sumana Chakravarty

http://www.w3.org/2001/XMLSchema#string

P2860

Development of a metabolically active, non-replicating sporozoite vaccine to prevent Plasmodium falciparum malaria

Protection of humans against malaria by immunization with radiation-attenuated Plasmodium falciparum sporozoites

Severe falciparum malaria. World Health Organization, Communicable Diseases Cluster

Clinical outcome of experimental human malaria induced by Plasmodium falciparum-infected mosquitoes.

Phase 1/2a study of the malaria vaccine candidate apical membrane antigen-1 (AMA-1) administered in adjuvant system AS01B or AS02A.

Clinical manifestations of Plasmodium falciparum malaria experimentally induced by mosquito challenge.

Laboratory-based versus non-laboratory-based method for assessment of cardiovascular disease risk: the NHANES I Follow-up Study cohort

Quantitative dynamics of Plasmodium yoelii sporozoite transmission by infected anopheline mosquitoes

Rationale and plans for developing a non-replicating, metabolically active, radiation-attenuated Plasmodium falciparum sporozoite vaccine.

Continuation of chloroquine-susceptible Plasmodium falciparum parasitemia in volunteers receiving chloroquine therapy.

P304

e13490

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0013490

http://www.w3.org/2001/XMLSchema#string

P407

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

5

http://www.w3.org/2001/XMLSchema#string

P50

Christopher V Plowe

Matthew Laurens

Stephen L Hoffman

P577

2010-10-21T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

47645640

http://www.w3.org/2001/XMLSchema#string

P698

21042404

http://www.w3.org/2001/XMLSchema#string

P921

Plasmodium falciparum

Anopheles stephensi

P932

2958836

http://www.w3.org/2001/XMLSchema#string